Search

Search Constraints

You searched for: Author/Creator Walker, Brian A.

Search Results

1. Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014‐04 (Etoile du Nord) trial. (19th June 2019)

3. Chromothripsis as a pathogenic driver of multiple myeloma. (March 2022)

4. A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations. (November 2019)

5. High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse. (9th July 2021)

6. Monitoring treatment response and disease progression in myeloma with circulating cell‐free DNA. (10th November 2020)

7. Improved risk stratification in myeloma using a microRNA‐based classifier. (30th May 2013)

8. Monitoring treatment response and disease progression in myeloma with circulating cell‐free DNA. (10th November 2020)